Bexion Pharmaceuticals
Corporate Video
Senior Management
Senior Management
Board of Directors
Board of Directors
Clinical Advisory Board
Scientific Advisory Board
Scientific Advisory Board
Bexion Milestones
Making Significant Progress
Bexion Media
PRESS RELEASE
Bexion Pharmaceuticals Presenting BXQ-350 Data at ASCO 2020
May 13, 2020
For Immediate Release, Covington, KY May 13, 2020 Bexion Pharmaceuticals announced today that the following three abstracts submitted to the 2020 American Society of Clinical Oncology (ASCO) have been accepted for oral or poster presentation: Oral Presentation Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas: First-in-human, first-in-class phase I trial. […]
read more
Bexion Pharmaceuticals president and CEO Ray Takigiku Interviewed by Cincinnati Public Radio
May 22, 2019
Bexion Pharmaceuticals president and CEO Ray Takigiku was interviewed by Cincinnati Public Radio on May 22, 2019. Click here to read more and listen to the interview.
read more